Abbott India Ltd
About
[
edit
]
Abbott India is engaged in the business of manufacturing, selling, distribution and marketing of Pharmaceuticals.
[
add key points
]
- Market Cap ₹ 30,578 Cr.
- Current Price ₹ 14,389
- High / Low ₹ 18,680 / 12,500
- Stock P/E 47.1
- Book Value ₹ 1,065
- Dividend Yield 0.74 %
- ROCE 35.2 %
- ROE 26.7 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 21.10% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.65%
- Company has been maintaining a healthy dividend payout of 49.80%
Cons
- Stock is trading at 13.52 times its book value
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
788 | 845 | 980 | 948 | 906 | 999 | 1,055 | 1,078 | 961 | 1,064 | 1,055 | 1,095 | |
682 | 734 | 786 | 801 | 753 | 825 | 851 | 839 | 823 | 831 | 814 | 854 | |
Operating Profit | 107 | 111 | 194 | 146 | 153 | 174 | 204 | 240 | 138 | 233 | 241 | 242 |
OPM % | 14% | 13% | 20% | 15% | 17% | 17% | 19% | 22% | 14% | 22% | 23% | 22% |
Other Income | 59 | 22 | 25 | 38 | 29 | 30 | 29 | 28 | 28 | 28 | 22 | 15 |
Interest | 2 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | 3 | 4 | 5 | 4 |
Depreciation | 4 | 4 | 4 | 4 | 5 | 15 | 15 | 15 | 15 | 14 | 14 | 15 |
Profit before tax | 159 | 129 | 214 | 180 | 177 | 187 | 216 | 251 | 149 | 242 | 244 | 238 |
Tax % | 37% | 36% | 36% | 35% | 36% | 37% | 18% | 25% | 25% | 26% | 26% | 26% |
Net Profit | 100 | 82 | 138 | 117 | 113 | 117 | 178 | 187 | 111 | 180 | 181 | 177 |
EPS in Rs | 47.10 | 38.78 | 64.79 | 55.08 | 53.27 | 55.03 | 83.92 | 87.86 | 52.22 | 84.87 | 85.05 | 83.36 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Figures in Rs. Crores
Nov 2008 | Nov 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
666 | 761 | 990 | 1,490 | 1,653 | 2,276 | 2,289 | 2,614 | 2,903 | 3,298 | 3,679 | 4,093 | 4,176 | |
590 | 663 | 920 | 1,315 | 1,470 | 2,009 | 1,977 | 2,250 | 2,505 | 2,774 | 3,074 | 3,336 | 3,321 | |
Operating Profit | 76 | 97 | 70 | 176 | 183 | 267 | 312 | 365 | 398 | 525 | 605 | 757 | 854 |
OPM % | 11% | 13% | 7% | 12% | 11% | 12% | 14% | 14% | 14% | 16% | 16% | 18% | 20% |
Other Income | 26 | 29 | 36 | 20 | 51 | 49 | 48 | 50 | 57 | 117 | 113 | 114 | 93 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 2 | 4 | 2 | 9 | 16 |
Depreciation | 7 | 9 | 11 | 15 | 19 | 22 | 15 | 14 | 16 | 16 | 17 | 60 | 58 |
Profit before tax | 94 | 117 | 94 | 180 | 215 | 295 | 344 | 398 | 436 | 621 | 699 | 803 | 873 |
Tax % | 33% | 34% | 35% | 33% | 33% | 33% | 34% | 36% | 37% | 35% | 36% | 26% | |
Net Profit | 63 | 78 | 61 | 120 | 145 | 198 | 229 | 255 | 277 | 401 | 450 | 593 | 649 |
EPS in Rs | 45.97 | 56.68 | 44.56 | 56.66 | 68.10 | 93.39 | 107.75 | 120.12 | 130.19 | 188.82 | 211.93 | 279.04 | 305.50 |
Dividend Payout % | 30% | 30% | 38% | 30% | 25% | 25% | 29% | 29% | 31% | 29% | 31% | 90% |
Compounded Sales Growth | |
---|---|
10 Years: | 18% |
5 Years: | 12% |
3 Years: | 12% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | 23% |
5 Years: | 21% |
3 Years: | 29% |
TTM: | 9% |
Stock Price CAGR | |
---|---|
10 Years: | 28% |
5 Years: | 25% |
3 Years: | 36% |
1 Year: | -8% |
Return on Equity | |
---|---|
10 Years: | 25% |
5 Years: | 25% |
3 Years: | 26% |
Last Year: | 27% |
Balance Sheet
Figures in Rs. Crores
Nov 2008 | Nov 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
14 | 14 | 14 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | |
Reserves | 208 | 258 | 292 | 523 | 626 | 767 | 916 | 1,174 | 1,366 | 1,672 | 1,987 | 2,410 | 2,241 |
Borrowings | 1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 175 | 166 |
129 | 117 | 148 | 253 | 260 | 351 | 436 | 421 | 679 | 723 | 932 | 940 | 1,052 | |
Total Liabilities | 351 | 388 | 453 | 797 | 907 | 1,139 | 1,374 | 1,616 | 2,066 | 2,416 | 2,941 | 3,547 | 3,480 |
48 | 49 | 50 | 80 | 109 | 98 | 96 | 108 | 110 | 81 | 105 | 270 | 260 | |
CWIP | 3 | 0 | 1 | 0 | 1 | 1 | 4 | 3 | 6 | 2 | 1 | 2 | 4 |
Investments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
300 | 339 | 403 | 717 | 798 | 1,040 | 1,274 | 1,505 | 1,950 | 2,333 | 2,835 | 3,275 | 3,216 | |
Total Assets | 351 | 388 | 453 | 797 | 907 | 1,139 | 1,374 | 1,616 | 2,066 | 2,416 | 2,941 | 3,547 | 3,480 |
Cash Flows
Figures in Rs. Crores
Nov 2008 | Nov 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
87 | 37 | 46 | 24 | 101 | 155 | 215 | 249 | 307 | 153 | 499 | 626 | |
140 | -1 | -16 | 56 | -59 | -144 | -187 | -77 | -155 | -215 | -257 | -401 | |
-81 | -23 | -27 | -42 | -42 | -42 | -58 | -80 | -90 | -102 | -143 | -217 | |
Net Cash Flow | 146 | 13 | 3 | 38 | 1 | -31 | -30 | 91 | 62 | -165 | 99 | 8 |
Ratios
Figures in Rs. Crores
Nov 2008 | Nov 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 40% | 48% | 33% | 42% | 34% | 39% | 40% | 38% | 34% | 41% | 37% | 35% |
Debtor Days | 18 | 21 | 24 | 32 | 31 | 18 | 21 | 20 | 22 | 29 | 27 | 28 |
Inventory Turnover | 5.16 | 5.24 | 5.67 | 4.54 | 3.78 | 4.20 | 3.55 | 3.97 | 3.95 | 3.53 | 3.53 | 4.11 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 10 Feb
- Re-Appointment Of Ms. Anisha Motwani (DIN: 06943493) As Independent Director For A Further Term Of 5 (Five) Years With Effect From April 25, 2021 9 Feb
- Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended On December 31, 2020 9 Feb
- Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Jan
- Board Meeting Intimation for Approving The Text Of Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended On December 31, 2020 29 Jan
View all